drug store, pharmacy, chain drug store, drugstore, community pharmacy, drug chain, retail pharmacy

Other Services
Reprints / E-Prints
Submit News
White Papers

Supplier News Breaks Archives

Week of   

Week of Mon, Apr 15th, 2013

Novo Nordisk's new U.S. headquarters makes debut

Novo Nordisk has unveiled its new U.S. headquarters, a 731,000-square-foot facility in Plainsboro, N.J.

Wolters Kluwer tool lends pharmacies a hand in insurance matters

A new solution from Wolters Kluwer Health is aimed at helping retail pharmacies cut down on the time spent dealing with insurance issues.

Hershey to simplify nutrition information on packaging

The Hershey Co. plans to implement a more user-friendly food labeling system across its U.S. product portfolio.

AbbVie enlists Sofia Vergara for hypothyroidism campaign

Actress Sofia Vergara is helping to raise awareness about the importance of diagnosing and treating hypothyroidism — and adhering to prescribed medications — through a new campaign sponsored by AbbVie.

Coca-Cola introduces Caffeine Free Coke Zero

Coca-Cola Co. has added a no-caffeine product to its Coke Zero soft drink line.

Actavis launches Yaz generic after favorable patent ruling

Actavis Inc. has relaunched its Vestura oral contraceptive in the wake of a favorable court decision.

SymphonyIRI Group rebrands as IRI

SymphonyIRI Group Inc. is returning to its founding name of Information Resources Inc. and rebranding as IRI.

Promo gives consumers chance to star in Dr. Pepper ads

Dr. Pepper Snapple Group has announced "Be the Next /1," a national consumer contest that offers fans the chance to star in upcoming national television commercials and digital advertising for the Dr. Pepper soft drink brand.

Lay's Wavy gets new flavor, new look

Frito-Lay North America has extended its Lay's Wavy potato chip line with the introduction of Lay's Wavy Garlic & Sea Salt.

Taro cleared to market Topicort spray

Taro Pharmaceutical Industries Ltd. has received approval from the Food and Drug Administration for Topicort Topical Spray 0.25%.

Warner Chilcott receives FDA approval for Doryx tablets

Warner Chilcott has been cleared by the Food and Drug Administration to market 200-mg strength of Doryx delayed-release tablets.